- Home
- XYF vs ORGO Comparison
XYF vs ORGO Comparison
Compare XYF & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XYF
- ORGO
- Stock Information
- Founded
- XYF 2014
- ORGO 1985
- Country
- XYF China
- ORGO United States
- Employees
- XYF N/A
- ORGO N/A
- Industry
- XYF Finance: Consumer Services
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- XYF Finance
- ORGO Health Care
- Exchange
- XYF Nasdaq
- ORGO Nasdaq
- Market Cap
- XYF 582.9M
- ORGO 533.9M
- IPO Year
- XYF 2018
- ORGO N/A
- Fundamental
- Price
- XYF $13.41
- ORGO $5.34
- Analyst Decision
- XYF
- ORGO Buy
- Analyst Count
- XYF 0
- ORGO 2
- Target Price
- XYF N/A
- ORGO $5.50
- AVG Volume (30 Days)
- XYF 130.5K
- ORGO 1.7M
- Earning Date
- XYF 05-29-2025
- ORGO 05-08-2025
- Dividend Yield
- XYF 2.68%
- ORGO N/A
- EPS Growth
- XYF 28.68
- ORGO N/A
- EPS
- XYF 4.32
- ORGO N/A
- Revenue
- XYF $804,452,842.00
- ORGO $482,043,000.00
- Revenue This Year
- XYF N/A
- ORGO $3.31
- Revenue Next Year
- XYF N/A
- ORGO $12.50
- P/E Ratio
- XYF $2.98
- ORGO N/A
- Revenue Growth
- XYF 21.95
- ORGO 11.29
- 52 Week Low
- XYF $3.68
- ORGO $2.17
- 52 Week High
- XYF $17.70
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- XYF 52.84
- ORGO 67.16
- Support Level
- XYF $12.50
- ORGO $5.14
- Resistance Level
- XYF $14.45
- ORGO $5.42
- Average True Range (ATR)
- XYF 1.00
- ORGO 0.28
- MACD
- XYF -0.02
- ORGO 0.09
- Stochastic Oscillator
- XYF 71.80
- ORGO 85.09
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.